BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
20
|
23 |
BTD |
P43251
|
biotinidase
|
Enzyme
|
1.5E-07 |
0.628 |
0.654 |
7
|
5 |
BMP2 |
P12643
|
bone morphogenetic protein 2
|
Signaling
|
0.99 |
0.432 |
0.846 |
1
|
1 |
BDNF |
P23560
|
brain derived neurotrophic factor
|
Signaling
|
0.66 |
0.345 |
0.923 |
16
|
16 |
BCKDHB |
P21953
|
branched chain keto acid dehydrogenase E1 subunit beta
|
Enzyme
|
4.3E-09 |
0.682 |
0.500 |
5
|
13 |
BPTF |
Q12830
|
bromodomain PHD finger transcription factor
|
|
1.00 |
0.560 |
0.769 |
11
|
12 |
BTNL2 |
Q9UIR0
|
butyrophilin like 2
|
Enzyme modulator
|
8.6E-11 |
0.546 |
0.808 |
15
|
15 |
CMIP |
Q8IY22
|
c-Maf inducing protein
|
Transcription factor
|
1.00 |
0.682 |
0.577 |
20
|
27 |
CSK |
P41240
|
C-terminal Src kinase
|
Kinase
|
1.00 |
0.606 |
0.692 |
11
|
6 |
CLEC16A |
Q2KHT3
|
C-type lectin domain containing 16A
|
|
0.28 |
0.612 |
0.654 |
29
|
38 |
C1QTNF3 |
Q9BXJ4
|
C1q and TNF related 3
|
|
1.8E-07 |
0.695 |
0.577 |
1
|
2 |
C1QTNF7 |
Q9BXJ2
|
C1q and TNF related 7
|
|
9.0E-05 |
0.861 |
0.192 |
4
|
6 |
C1QTNF3-AMACR |
|
C1QTNF3-AMACR readthrough (NMD candidate)
|
|
|
0.931 |
0.154 |
2
|
2 |
C1QTNF7-AS1 |
|
C1QTNF7 antisense RNA 1
|
|
|
1.000 |
0.038 |
5
|
7 |
CDH13 |
P55290
|
cadherin 13
|
|
7.1E-04 |
0.501 |
0.846 |
20
|
29 |
CPED1 |
A4D0V7
|
cadherin like and PC-esterase domain containing 1
|
|
1.9E-24 |
0.769 |
0.500 |
6
|
15 |
CALCR |
P30988
|
calcitonin receptor
|
G-protein coupled receptor
|
3.1E-09 |
0.464 |
0.846 |
8
|
9 |
CALCRL |
Q16602
|
calcitonin receptor like receptor
|
G-protein coupled receptor
|
0.99 |
0.653 |
0.692 |
2
|
2 |
CADPS |
Q9ULU8
|
calcium dependent secretion activator
|
Calcium-binding protein
|
1.5E-05 |
0.805 |
0.154 |
12
|
9 |
CAMKK2 |
Q96RR4
|
calcium/calmodulin dependent protein kinase kinase 2
|
Kinase
|
9.2E-02 |
0.617 |
0.654 |
2
|
2 |
CREB3L3 |
Q68CJ9
|
cAMP responsive element binding protein 3 like 3
|
|
8.1E-14 |
0.792 |
0.192 |
1
|
1 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
35
|
41 |
CASC19 |
|
cancer susceptibility 19
|
|
|
0.769 |
0.423 |
7
|
29 |
CASC8 |
|
cancer susceptibility 8
|
|
|
0.670 |
0.462 |
14
|
17 |